Irwin Naturals
Yohimbe-Plus Maximum Enhancement
Serving
1 Liquid Softgel(s)
Per container
50
Form
capsule-unknown
UPC
710363262402
DSLD
Formula hash
42e92e40fa90
Brand context
Catalog
314
products
With avoid flag
269
products
FDA recalls
0
history
CAERS
12
reports
Avoid-flaggedObjective label signals
Flagged excipients
1
1 avoid · 0 caution
FDA recalls
0
no recall history
CAERS reports
11
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.
Supplement Facts
11 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Flaxseed Oil otherUNII · 84XB4DV00W | 1010 mg | — |
| Yohimbe extract YohimbeherbUNII · 9M051HS3S5 | 205 mg | — |
| Ashwagandha extract Ashwagandhaherb LiverTox B | 200 mg | — |
| Damiana powder Damianaherb | 100 mg | — |
| Eleuthero Extract herbUNII · ZQH6VH092Z | 100 mg | — |
| Epimedium extract Epimediumherb | 100 mg | — |
| Muira Puama powder Muira Puamaherb | 100 mg | — |
| Tribulus extract TribulusherbUNII · 4X4HLN92OT | 100 mg | — |
| Ginkgo Extract Ginkgoherb LiverTox D | 20 mg | — |
| Asian Ginseng extract Oriental Ginsengherb | 20 mg | — |
| BioPerine Complex Proprietary Blendother | 4 mg | — |
Flagged excipients
1 flagged · authority citations
- ● AVOIDTitanium Dioxidecolor
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
FDA CAERS · adverse event context
11
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Other ingredients
Gelatin · purified Water · Glycerin · Caramel · Soy Lecithin · Beeswax · Silicon Dioxide